ArticleIndian journal of endocrinology and metabolism2012
Metabolic syndrome in the Middle East.
Article in Indian journal of endocrinology and metabolism, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- The Prevalence of Metabolic Syndrome in Ethiopian Population: A Systematic Review and Meta-analysis.Journal of obesity · 2020Pooled it
- Prevalence and trends of metabolic syndrome among adults in the asia-pacific region: a systematic review.BMC public health · 2017Pooled it
- Arginine vasopressin: A promising therapeutic target for metabolic syndrome.The Journal of pharmacology and experimental therapeutics · 2026Review
- Cross-Cultural Perspectives on Metabolic Syndrome Management and Attitudes Toward Using Digital Health Tools in Two Distinct Populations: Protocol for a Qualitative Descriptive Study.JMIR research protocols · 2026Article
- Sleep Disturbances Associated with Different Systems of the Body: Underlying Mechanisms Involved and Consequences.Current medicinal chemistry · 2025Review
- Prevalence and Risk Factors of Peripheral Artery Disease in Diabetic Patients: Insights from a Retrospective Cross-Sectional and Cohort Study in Abu Dhabi.Vascular health and risk management · 2025Article
- Article
- Clinical Management of Metabolic Syndrome Among the Population Attending Geriatric Outpatient Clinics in Qatar.Cureus · 2024Article
- Unsupervised clustering identified clinically relevant metabolic syndrome endotypes in UK and Taiwan Biobanks.iScience · 2024Article
- Reformulating ice cream to improve postprandial glucose response: an opportunity for industry to create shared value.Frontiers in nutrition · 2024Article
- Regional expert opinion: Management of heart failure with preserved ejection fraction in the Middle East, North Africa and Turkey.ESC heart failure · 2023Review
- Independent association between age- and sex-specific metabolic syndrome severity score and cardiovascular disease and mortality.Scientific reports · 2023Article
- Abdominal volume index, waist-to-height ratio, and waist circumference are optimal predictors of cardiometabolic abnormalities in a sample of Lebanese adults: A cross-sectional study.PLOS global public health · 2023Article
- Total Testosterone to Estradiol Ratio as a Predictor Marker of Metabolic Syndrome in Males.Archives of Razi Institute · 2022Article
- Correlation of circulating miRNA-33a and miRNA-122 with lipid metabolism among Egyptian patients with metabolic syndrome.Journal, genetic engineering & biotechnology · 2021Article
- A nationwide study of metabolic syndrome prevalence in Iran; a comparative analysis of six definitions.PloS one · 2021Article
- The Epidemic Of The Metabolic Syndrome Among The Palestinians In The Gaza Strip.Diabetes, metabolic syndrome and obesity : targets and therapy · 2019Article
- Incidence and risk factors for metabolic syndrome among urban, adult Sri Lankans: a prospective, 7-year community cohort, follow-up study.Diabetology & metabolic syndrome · 2019Article
- Metabolic syndrome among adolescents in Dubai, United Arab Emirates, is attributable to the high prevalence of low HDL levels: a cross-sectional study.BMC public health · 2018Article
- Depression, Metabolic Syndrome, and Locus of Control in Arab Americans Living in the DC Metropolitan Area: A Structural Equation Model.Journal of immigrant and minority health · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Metabolic syndrome (MS) is a combination of medical disorders that, in concert, increase the risk of developing cardiovascular disease and diabetes. It affects about one in four people in the Middle East, and prevalence increases with age. The aim of current review is to discuss the prevalence of MS and its component in different regions in the Middle East. The recorded high prevalence of the MS and its key cardiovascular risk factors (15-60%) among Middle East population mandates the need for a national and international prevention programs to combat obesity, diabetes, hypertension, dyslipidemia, smoking and related comorbidities. Consideration of early prevention and control is of utmost importance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.